Skip to content

Amino Acid and Intestinal Protein Metabolism : Working Study

Physiological Study on Glutamine and Leucine Effects on Intestinal Protein Metabolism

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01254110
Acronym
Intesmetapro
Enrollment
36
Registered
2010-12-06
Start date
2009-04-30
Completion date
2012-02-29
Last updated
2013-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Proteinic Synthesis, Proteolytic System, Transduction Pathway

Brief summary

Gut protein metabolism that could be influenced by protein supply is involved in the regulation of several physiological functions such as gut barrier function and represents a major contribution in the whole-body protein turnover. Intracellular pathways implicated in the transduction of amino acids effects remained unknown in the human gut. Thus, the aim of the present project is to evaluate and to understand the effects of amino acids (glutamine, leucine) on gut protein metabolism (synthesis and degradation) in young healthy humans.

Interventions

None listed

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* volunteers with seronegativity for HIV1 and HIV2 and HCV and HVB * good nutritional state with physical indication mass included between 18,5 and 25kg/m2 * non-smoking volunteers * volunteers without digestive, allergic or haemorrhagic history * volunteers without progressive disease * digestive endoscopy tolerance * age \>=18 and \<= 50years * consent obtained from volunteers

Exclusion criteria

* smoking volunteers * volunteers with digestive, or allergic history * volunteers with haemorrhagic sign * pregnancy * progressive digestive disease * significant progressive disease * volunteers with therapeutic treatment (aspirin) * digestive endoscopy intolerance * volunteers with neurological disorder or with delicate psychological state

Design outcomes

Primary

MeasureTime frame
assessment of intestinal protein synthesis stimulation by Leucine or glutamine in duodenal biopsy18 months

Secondary

MeasureTime frame
Assessment of involved signaling pathways18 months
Assessment of intestinal proteolysis18 months
Assessment of protein synthesis rate in intestinal mitochondria18 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026